Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment

研究成果: Article同行評審

11 引文 斯高帕斯(Scopus)

指紋

深入研究「Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment」主題。共同形成了獨特的指紋。

Medicine & Life Sciences